MCA1 detection of Histone H3 serine 10 phosphorylation, a novel biomarker for determination of mitotic indices

Human Antibodies

Volumn 15, Issue 3, 2006, Pages 71-80

  Rayzman, Veronika M ^a,b   Sentry, John W ^a  

^a ALFRED HOSPITAL   (Australia)

^b AUSTIN HOSPITAL   (Australia)

Author keywords

Biomarkers; Cell proliferation; Epstein Barr virus immortalisation; Histone H3; Human B lymphocytes; MCA1; Mitotic chromosomal autoantigens

Indexed keywords

AUTOANTIBODY; AUTOANTIGEN; BIOLOGICAL MARKER; HISTONE H3; MITOTIC CHROMOSOMAL AUTOANTIGEN 1; MITOTIC CHROMOSOMAL AUTOANTIGEN 1 REACTIVE ANTIBODY; REAGENT; SERINE; UNCLASSIFIED DRUG;

AGED; ANTIBODY AFFINITY; ANTIBODY DETECTION; ANTIBODY ENGINEERING; ANTIBODY PRODUCTION; ARTICLE; B LYMPHOCYTE; CARCINOGENESIS; CELL IMMORTALIZATION; CELL PROLIFERATION; CHROMATIN; COMPLEMENTARITY DETERMINING REGION; CONTROLLED STUDY; EPSTEIN BARR VIRUS; FEMALE; FLUORESCENCE ACTIVATED CELL SORTING; GENE LIBRARY; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IMMUNOGLOBULIN VARIABLE REGION; IMMUNOLOGICAL PROCEDURES; IMMUNOMODULATION; MITOSIS INDEX; PERIPHERAL BLOOD MONONUCLEAR CELL; PHAGE DISPLAY; PRIORITY JOURNAL; PROGNOSIS; PROTEIN PHOSPHORYLATION; RIBOSOME; STAINING; VIRUS INFECTION; YEAST;

EID: 33750257648     PISSN: 10932607     EISSN: None     Source Type: Journal    
DOI: 10.3233/hab-2006-15302     Document Type: Article

References (54)

1. C.A. von Mühlen and E.M. Tan, Autoantibodies in the diagnosis of systemic rheumatic diseases, Semin Arthritis Rheum 24 (1995), 323-358.
2. J.B. Peter and Y. Shoenfeld, eds, Autoantibodies. Amsterdam, Netherlands: Elsevier, 1996.
3. N.R. Rose and I.R. Macay, eds, The autoimmune diseases. New York, NY: Academic Press, 1998.
4. V.M. Gitlits, S.L. Macaulay, B.H. Toh and J.W. Sentry, Novel human autoantibodies to phosphoepitopes on mitotic chromosomal autoantigens (MCAs), J Investig Med 48 (2000), 172-182.
5. T. Hirota, J.J. Lipp, B.H. Toh and J.M. Peters, Histone H3 serine 10 phosphorylation by Aurora B causes HP1 dissociation from heterochromatin, Nature 438 (2005), 1176-1180.
6. T. Furukawa, Epstein-Barr virus: comparison of different strains for their biological activities in vitro, Res Commun Chem Pathol Pharmacol 10 (1975), 543-553.
7. T. Katsuki and Y. Hinuma, Characteristics of cell lines derived from human leukocytes transformed by different strains of Epstein-Barr virus, Int J Cancer 15 (1975), 203-210.
8. G.D. Sorenson and O.S. Pettengill, In vitro and in vivo alterations of long-term murine plasmacytoma cultures, Arch Intern Med 135 (1975), 114-118.
9. V.M. Gitlits, J.W. Sentry, M.L. Matthew, A.I. Smith and B.H. Toh, Autoantibodies to evolutionarily conserved epitopes of enolase in a patient with discoid lupus erythematosus, Immunology 92 (1997), 362-368.
10. U.K. Laemmli, Cleavage of structural proteins during the assembly of head bacteriophage T4, Nature 227 (1970), 680-688.
11. V.M. Gitlits, J.W. Sentry, M.L.S.M. Matthew, A.I. Smith and B.H. Toh, Synapsin I Identified as a Novel Brain-Specific Autoantigen, J Investig Med 49 (2001), 276-283.
12. S.L. Schreiber and G.R. Crabtree, The mechanism of action of cyclosporin A and FK506, Immunol Today 13 (1992), 136-142.
13. G.A. Pangalis, M.K. Angelopoulou, T.P. Vassilakopoulos, M.P. Siakantaris and C. Kittas, B-chronic lymphocytic leukemia, small lymphocytic lymphoma, and lymphoplasmacytic lymphoma, including Waldenstrom's macroglobulinemia: a clinical, morphologic, and biologic spectrum of similar disorders, Semin Hematol 36 (1999) 104-114.
14. D. Levitt, D. Duber-Stull and A.R. Lawton, T-cell-dependent and independent plasma cell differentiation induced by Escherichia coli Lipopolysaccharide in human peripheral blood lymphocytes, Clin Immunol Immunopathol 18 (1981), 309-321.
15. D. Goossens, F. Champomier, P. Rouger and C. Salmon, Human monoclonal antibodies against blood group antigens. Preparation of a series of stable EBV immortalized B clones producing high levels of antibody of different isotypes and specificities, J Immunol Methods 101 (1987) 193-200.
16. M. Steinitz, S. Tamir, J.E. Frodin, A.K. Lefvert and H. Mellstedt, Human monoclonal anti-idiotypic antibodies. I. Establishment of immortalized cell lines from a tumor patient treated with mouse monoclonal antibodies, J Immunol 141 (1988), 316-322.
17. V. Boyer, H. Broly, S. Souche, P. Madaule, J. Rossier, D. Zagury and C. Desgranges, Characterization and large production of human monoclonal antibodies against the HIV-1 envelope, Clin Exp Immunol 83 (1991), 452-459.
18. W. Richter, J. Endl, T.H. Eiermann, M. Brandt, R. Kientsch-Engel, C. Thivolet, H. Jungfer and W.A. Scherbaum, Human monoclonal islet cells antibodies from a patient with insulin-dependent diabetes mellitus reveal glutamate decarboxylase as the target antigen, Proc Natl Acad Sci. USA 89 (1992), 8467-8471.
19. H. Celenligil and J.L. Ebersole, Characteristics and responses of EBV immortalized B cells from periodontal disease patients, Oral Dis 3 (1997), 262-271.
20. S.P. Cole, B.G. Campling, T. Atlaw, D. Kozbor and J.C. Roder, Human monoclonal antibodies, Mol Cell Biochem 62 (1984), 109-120.
21. G. Tosato, R.M. Blaese and R. Yarchoan, Relationship between immunoglobulin production and immortalization by Epstein Barr virus, J Immunol 135 (1985), 959-964.
22. K.M. Thompson, D.W. Hough, P.J. Maddison, M.D. Melamed and N. Hughes-Jones, The efficient production of stable, human monoclonal antibody-secreting hybridomas from EBV-transformed lymphocytes using the mouse myeloma X63-Ag8.653 as a fusion partner, J Immunol Methods 94 (1986), 7-12.
23. K. James, J. Gardner, G. Skibinski, M. McCann, R. Thorpe, A. Gearing and J. Gordon, Cell surface phenotype, cytokines, and antibody gene expression in immortalized human B cell lines, Hum Antibodies Hybridomas 1 (1990), 145-153.
24. K. Syren, L. Lindsay, B. Stoehrer, K. Jury, F. Luhder, S. Baekkeskov and W. Richter, Immune reactivity of diabetes-associated human monoclonal autoantibodies defines multiple epitopes and detects two domain boundaries in glutamate decarboxylase, J Immunol 157 (1996), 5208-5214.
25. G. Skibinski and K. James, Reactivation of antibody genes in Epstein-Barr virus transformed human B cell lines. A preliminary report, Arch Immunol Ther Exp (Warsz) 37 (1989), 295-300.
26. C. Venkataraman, G. Shankar, G. Sen, S. Bondada, Bacterial lipopolysaccharide induced B cell activation is mediated via a phosphatidylinositol 3-kinase dependent signaling pathway, Immunol Lett 69 (1999), 233-238.
27. S.J. Kim, Y. Park and H.J. Hong, Antibody engineering for the development of therapeutic antibodies, Mol Cells 20 (2005), 17-29.
28. L. Sanz, A.M. Cuesta, M. Compte and L. Alvarez-Vallina, Antibody engineering: facing new challenges in cancer therapy, Acta Pharmacol Sin 26 (2005), 641-648.
29. R. Bravo, R. Frank, P.A. Blundell and H. Macdonald-Bravo, Cyclin/PCNA is the auxiliary protein of DNA polymerase-delta, Nature 326 (1987), 515-517.
30. G.F. Morris and M.B. Mathews, Regulation of proliferating cell nuclear antigen during the cell cycle, J Biol Chem 264 (1989), 13856-13864.
31. G. Cattoretti, M.H. Becker, G. Key, M. Duchrow, C. Schluter, J. Galle and J. Gerdes. Monoclonal antibodies against recombinant parts of the Ki-67 antigen (MIB 1 and MIB 3) detect proliferating cells in microwave-processed formalin-fixed paraffin sections, J Pathol 168 (1992), 357-363.
32. J. Gerdes, H. Lemke, H. Baisch, H.H. Wacker, U. Schwab and H. Stein, Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67, J Immunol 133 (1984), 1710-1715.
33. J. Gerdes, Ki-67 and other proliferation markers useful for immunohistological diagnostic and prognostic evaluations in human malignancies, Semin Cancer Biol. 1 (1990), 199-206.
34. J. Gerdes, L. Li, C. Schlueter, M. Duchrow, C. Wohlenberg, C. Gerlach, I. Stahmer, S. Kloth, E. Brandt and H.D. Flad, Immunobiochemical and molecular biologic characterization of the cell proliferation-associated nuclear antigen that is defined by monoclonal antibody Ki-67, Am J Pathol 138 (1991), 867-873.
35. R.K. Brachmann, p53 mutants: the achilles' heel of human cancers? Cell Cycle 3 (2004), 1030-1034.
36. P.A. Hall and W.G. McCluggage, Assessing p53 in clinical contexts: unlearned lessons and new perspectives, J Pathol 208 (2006), 1-6.
37. H.J. Heidebrecht, F. Buck, J. Steinmann, R. Sprenger, H.H. Wacker and R. Parwaresch, p100: a novel proliferation-associated nuclear protein specifically restricted to cell cycle phases S, G2, and M, Blood 90 (1997), 226-233.
38. P. Rudolph, R. Knuchel, E. Endl, H.J. Heidebrecht, F. Hofstader and R. Parwaresch, The immunohistochemical marker Ki-S2: cell cycle kinetics and tissue distribution of a novel proliferation-specific antigen, Mod Pathol 11 (1998), 450-456.
39. H.J. Heidebrecht, S. Adam-Klages, M. Szczepanowski, M. Pollmann, F. Buck, E. Endl, M.L. Kruse, P. Rudolph and R. Parwaresch, repp86: A human protein associated in the progression of mitosis, Mol Cancer Res 1 (2003), 271-279.
40. J.J. Blow and A. Dutta, Preventing re-replication of chromosomal DNA, Nat Rev Mol Cell Biol 6 (2005), 476-486.
41. N.H. Waseem and D.P. Lane, Monoclonal antibody analysis of the proliferating cell nuclear antigen (PCNA). Structural conservation and the detection of a nucleolar form, J Cell Sci 96 (1990), 121-129.
42. G. Key, M.H. Becker, B. Baron, M. Duchrow, C. Schluter, H.D. Flad and J. Gerdes, New Ki-67-equivalent murine monoclonal antibodies (MIB 1-3) generated against bacterially expressed parts of the Ki-67 cDNA containing three 62 base pair repetitive elements encoding for the Ki-67 epitope, Lab Invest 68 (1993), 629-636.
43. M. Matsuta, S. Kimura, G. Kosegawa, S. Kon and M. Matsuta, Immunohistochemical detection of Ki-67 in epithelial skin tumors in formalin-fixed paraffin-embedded tissue sections using a new monoclonal antibody (MIB-1), J Dermatol 23 (1996), 147-152.
44. L. Neder, B.O. Colli, H.R. Machado, C.G. Carlotti Jr, A.C. Santos and L. Chimelli, MTB-1 labeling index in astrocytic tumors-a clinicopathologic study, Clin Neuropathol 23 (2004), 262-270.
45. I.S. Scott, L.S. Morris, S.M. Rushbrook, K. Bird, S.L. Vowler, N.G. Burnet and N. Coleman, Immunohistochemical estimation of cell cycle entry and phase distribution in astrocytomas: applications in diagnostic neuropathology, Neuropathol Appl Neurobiol 31 (2005), 455-466.
46. A. Soling, M. Sackewitz, M. Volkmar, D. Schaarschmidt, R. Jacob, H.J. Holzhausen and N.G. Rainov, Minichromosome maintenance protein 3 elicits a cancer-restricted immune response in patients with brain malignancies and is a strong independent predictor of survival in patients with anaplastic astrocytoma, Clin Cancer Res 11 (2005), 249-258.
47. R. Ricco, A. Cimmino, G. Renzulli, G. Serio, A. Lozupone, T. Lettini, A. Pece, C. Giardina and V.P. Delfino, Real-time quantification of the proliferative state in astrocytomas, Anal Quant Cytol Histol 22 (2000), 213-217.
48. C. Mochen, R. Giardini, A. Costa and R. Silvestrini, MIB-1 and S-phase cell fraction predict survival in non-Hodgkin's lymphomas, Cell Prolif 30 (1997), 37-47.
49. P.A. Ellis, A. Makris, S.A. Burton, J. Titley, M.G. Ormerod, J. Salter, T.J. Powles, I.E. Smith and M. Dowsett, Comparison of MIB-1 proliferation index with S-phase fraction in human breast carcinomas, Br J Cancer 73 (1996), 640-643.
50. M. Krams, H.J. Heidebrecht, B. Hero, F. Berthold, D. Harms, R. Parwaresch and P. Rudolph, Repp86 expression and outcome in patients with neuroblastoma, J Clin Oncol 21 (2003), 1810-1818.
51. M.L. Whitfield, L.K. George, G.D. Grant and C.M. Perou, Common markers of proliferation, Nat Rev Cancer 6 (2006), 99-106.
52. I. D'Agnano, M. Cosimelli, A. La Pera, F. Cavaliere, E. Mannella, D. Giannarelli, R. Cavaliere and G. Zupi, Flow cytometric analysis of DNA content and cell kinetics in colorectal carcinoma, Anticancer Res 13 (1993), 699-703.
53. R. Gorodetsky, L. Levdansky, I. Ringel and A. Vexler, Paclitaxel-induced modification of the effects of radiation and alterations in the cell cycle in normal and tumor mammalian cells, Radiat Res 150 (1998), 283-291.
54. T.C. Pina, I.T. Zapata, J.B. Lopez, J.L. Perez, P.P. Paricio and P.M. Hernandez, DNA aneuploidy, S-phase fraction and nuclear p53 positivity in non-small cell lung carcinoma, Clin Biochem 32 (1999), 347-354.